Stock & Company Details
ATAI Life Sciences N.V. $ATAI
Price:
46,691,331
368M
$2.7B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-7.87
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Commercial Services
ATAI technical indicators
Latest ATAI Life Sciences N.V. (ATAI) technical indicators as of 2026-07-27: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
73.67 0.3%
MACD:
0.73 0.5%
SMA 50:
$4.93 1.2%
SMA 200:
$4.38 0.2%
EMA 20:
$6.17 1.7%
Bollinger Bands:
7.95 / 4.04
Stochastic:
98.08 0.2%
ADX 14:
41.28 3.5%
ATR 14:
0.33 6.3%
CCI 20:
84.10 12.5%
OBV:
416.98M 2.3%
ROC 12:
34.52% 11.2%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
Finance Bot
Ask your questions
Start by typing a question below.
